Epigral Limited

NSEI:EPIGRAL Stock Report

Market Cap: ₹84.8b

Epigral Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Kaushal Soparkar

Chief executive officer

₹43.9m

Total compensation

CEO salary percentage9.2%
CEO tenure8.6yrs
CEO ownership0.5%
Management average tenureno data
Board average tenure8.6yrs

Recent management updates

Recent updates

Here's Why Epigral (NSE:EPIGRAL) Has Caught The Eye Of Investors

Dec 18
Here's Why Epigral (NSE:EPIGRAL) Has Caught The Eye Of Investors

Epigral Limited's (NSE:EPIGRAL) Shares Leap 29% Yet They're Still Not Telling The Full Story

Jul 04
Epigral Limited's (NSE:EPIGRAL) Shares Leap 29% Yet They're Still Not Telling The Full Story

Epigral Limited (NSE:EPIGRAL) Looks Just Right With A 27% Price Jump

Apr 19
Epigral Limited (NSE:EPIGRAL) Looks Just Right With A 27% Price Jump

Epigral Limited (NSE:EPIGRAL) Soars 28% But It's A Story Of Risk Vs Reward

Feb 23
Epigral Limited (NSE:EPIGRAL) Soars 28% But It's A Story Of Risk Vs Reward

Epigral (NSE:EPIGRAL) Might Be Having Difficulty Using Its Capital Effectively

Feb 21
Epigral (NSE:EPIGRAL) Might Be Having Difficulty Using Its Capital Effectively

Capital Investment Trends At Meghmani Finechem (NSE:MFL) Look Strong

Apr 05
Capital Investment Trends At Meghmani Finechem (NSE:MFL) Look Strong

With EPS Growth And More, Meghmani Finechem (NSE:MFL) Makes An Interesting Case

Sep 28
With EPS Growth And More, Meghmani Finechem (NSE:MFL) Makes An Interesting Case

Meghmani Finechem's (NSE:MFL) Promising Earnings May Rest On Soft Foundations

May 03
Meghmani Finechem's (NSE:MFL) Promising Earnings May Rest On Soft Foundations

Meghmani Finechem Limited's (NSE:MFL) Business Is Yet to Catch Up With Its Share Price

Nov 22
Meghmani Finechem Limited's (NSE:MFL) Business Is Yet to Catch Up With Its Share Price

CEO Compensation Analysis

How has Kaushal Soparkar's remuneration changed compared to Epigral's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹3b

Jun 30 2024n/an/a

₹3b

Mar 31 2024₹44m₹4m

₹2b

Dec 31 2023n/an/a

₹2b

Sep 30 2023n/an/a

₹2b

Jun 30 2023n/an/a

₹3b

Mar 31 2023₹62m₹4m

₹4b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹4b

Jun 30 2022n/an/a

₹3b

Mar 31 2022₹32m₹4m

₹3b

Mar 31 2021₹30m₹3m

₹1b

Mar 31 2020₹28m₹4m

₹1b

Mar 31 2019₹64m₹4m

₹2b

Mar 31 2018₹9m₹4m

₹2b

Compensation vs Market: Kaushal's total compensation ($USD516.79K) is above average for companies of similar size in the Indian market ($USD353.22K).

Compensation vs Earnings: Kaushal's compensation has been consistent with company performance over the past year.

CEO

Kaushal Soparkar (41 yo)

8.6yrs

Tenure

₹43,907,000

Compensation

Mr. Kaushal Ashisbhai Soparkar serves as Chief Executive Officer and until August 5, 2023 served as Managing Director and serves as Director of Epigral Limited (formerly known as Meghmani Finechem Limited)...

Board Members

NamePositionTenureCompensationOwnership
Maulik Patel
Chairman & MD8.6yrs₹43.91m7.53%
₹ 6.4b
Kaushal Soparkar
CEO & Executive Director8.6yrs₹43.91m0.51%
₹ 435.8m
Kanubhai Patel
Independent Non-Executive Director3.6yrs₹700.00kno data
Karana Patel
Non-Executive Director8.6yrs₹25.32m1.68%
₹ 1.4b
Sanjay Asher
Independent Non-Executive Director3.6yrs₹500.00kno data
Ankit Patel
Non-Executive Director8.6yrs₹41.27m5.41%
₹ 4.6b
Manubhai Patel
Independent Non-Executive Director7.6yrs₹875.00kno data
Darshan Patel
Non-Executive Director8.6yrs₹17.35m2.29%
₹ 1.9b
Nirali Parikh
Independent Non-Executive (Woman) Director9.8yrs₹725.00kno data
Raju Swamy
Independent Non-Executive Director3.6yrs₹400.00k0.010%
₹ 8.5m

8.6yrs

Average Tenure

43yo

Average Age

Experienced Board: EPIGRAL's board of directors are considered experienced (8.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Epigral Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullBP Wealth Management Private Limited
Meet VoraEmkay Global Financial Services Ltd.
Kameswari V. S. ChavaliFirstCall Research